GRI Bio, Inc. SEC filings GRI

GRI Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 11, 2020. Its latest annual report, Form ARS, was filed on Sep 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

GRI Bio, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Dec 29, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 17, 2025 —
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2025 —
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Sep 26, 2023 Sep 22, 2023
4 Insider transaction Aug 14, 2023 Aug 10, 2023
4 Insider transaction Aug 14, 2023 Aug 10, 2023
4 Insider transaction Aug 14, 2023 Aug 10, 2023
4 Insider transaction Aug 14, 2023 Aug 10, 2023
SC 13G Ownership over 5% (passive) May 3, 2023 —
SC 13G Ownership over 5% (passive) May 2, 2023 —
SC 13D Ownership over 5% (active) Apr 25, 2023 —
SC 13D Ownership over 5% (active) Apr 25, 2023 —
SC 13D Ownership over 5% (active) Apr 25, 2023 —
3 Initial insider ownership Apr 25, 2023 Apr 21, 2023
3 Initial insider ownership Apr 25, 2023 Apr 21, 2023
3 Initial insider ownership Apr 25, 2023 Apr 21, 2023
3 Initial insider ownership Apr 25, 2023 Apr 21, 2023
3 Initial insider ownership Apr 25, 2023 Apr 21, 2023
4 Insider transaction Apr 24, 2023 Apr 21, 2023
4 Insider transaction Apr 24, 2023 Apr 21, 2023
4 Insider transaction Apr 24, 2023 Apr 21, 2023
3 Initial insider ownership Apr 24, 2023 Apr 21, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2023 —
SC 13G/A Amended ownership over 5% (passive) Dec 27, 2022 —
4 Insider transaction Dec 15, 2022 Dec 13, 2022
SC 13G Ownership over 5% (passive) Sep 29, 2022 —
4 Insider transaction Jul 6, 2022 Jul 1, 2022
4 Insider transaction Jun 10, 2022 Jun 9, 2022
4 Insider transaction Jun 10, 2022 Jun 9, 2022
4 Insider transaction Jun 10, 2022 Jun 9, 2022
SC 13G Ownership over 5% (passive) May 23, 2022 —
SC 13G Ownership over 5% (passive) May 23, 2022 —
SC 13G Ownership over 5% (passive) May 18, 2022 —
4 Insider transaction Mar 9, 2022 Feb 23, 2022
3 Initial insider ownership Mar 9, 2022 Feb 23, 2022
4 Insider transaction Mar 1, 2022 Feb 15, 2022
4 Insider transaction Mar 1, 2022 Feb 15, 2022
SC 13G Ownership over 5% (passive) Feb 17, 2022 —
SC 13G Ownership over 5% (passive) Feb 15, 2022 —
4 Insider transaction Jun 4, 2021 Jun 2, 2021
4 Insider transaction May 27, 2021 May 25, 2021
4 Insider transaction May 18, 2021 May 14, 2021
4 Insider transaction May 18, 2021 May 14, 2021
4 Insider transaction May 18, 2021 May 14, 2021
4 Insider transaction May 18, 2021 May 14, 2021
4 Insider transaction May 18, 2021 May 14, 2021
4 Insider transaction May 18, 2021 May 14, 2021
3 Initial insider ownership May 18, 2021 May 11, 2021
SC 13D/A Amended ownership over 5% (active) Mar 16, 2021 —
SC 13D Ownership over 5% (active) Feb 16, 2021 —
4 Insider transaction Feb 12, 2021 Feb 12, 2021
4 Insider transaction Feb 12, 2021 Feb 12, 2021
4 Insider transaction Feb 12, 2021 Feb 12, 2021
4 Insider transaction Feb 12, 2021 Feb 12, 2021
3 Initial insider ownership Feb 10, 2021 Feb 9, 2021
3 Initial insider ownership Feb 10, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021
3 Initial insider ownership Feb 9, 2021 Feb 9, 2021

Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
, Emerging growth company
SEC CIK
1824293
Former names
Vallon Pharmaceuticals, Inc. (until Apr 21, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.